Lithium showed no clear difference in acceptability: total withdrawals compared with valproate (high certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with lamotrigine (very low certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with carbamazepine (low certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with quetiapine (very low certainty).
Lithium may leads to higher acceptability: total withdrawals compared with olanzapine (low certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with placebo (moderate certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with chlorpromazine (low certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with haloperidol (very low certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with zuclopenthixol (very low certainty).
Lithium probably leads to higher acceptability: total withdrawals compared with risperidone (moderate certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with aripiprazole (moderate certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with topiramate (high certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Lithium showed no clear difference in acceptability: total withdrawals compared with all antimanic agents (high certainty).